ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » New York » Endocrinology, Diabetes Metabolism

Top Endocrinology, Diabetes Metabolism Prescribers in New York

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
RODOLFO GUZMAN M.D.

Endocrinology, Diabetes Metabolism

25,257

$2.04M

707
528 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

9%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

46%
prescriptions for brand name drugs

Avg: 49%

$81
Average prescription price

Avg: $131

STELLA ILYAYEVA PHYSICIAN, P.C.

Endocrinology, Diabetes Metabolism

22,588

$2.6M

1044
838 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

4%
patients receiving schedule three controlled substances

Avg: 1%

6%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

54%
prescriptions for brand name drugs

Avg: 49%

$115
Average prescription price

Avg: $131

ANTHONY JUNG M.D

Endocrinology, Diabetes Metabolism

18,718

$1.75M

690
631 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

2%
patients receiving schedule three controlled substances

Avg: 1%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

54%
prescriptions for brand name drugs

Avg: 49%

$93
Average prescription price

Avg: $131

MATIN SHARAFATKHAH M.D

Endocrinology, Diabetes Metabolism

17,614

$2.68M

792
692 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

74%
prescriptions for brand name drugs

Avg: 49%

$152
Average prescription price

Avg: $131

MONICA SCANTLEBURY M.D.

Endocrinology, Diabetes Metabolism

14,047

$48.6K

202
192 are 65+

15%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 49%

$3
Average prescription price

Avg: $131

LONEIEN ONG

Endocrinology, Diabetes Metabolism

12,970

$725K

409
307 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

29%
prescriptions for brand name drugs

Avg: 49%

$56
Average prescription price

Avg: $131

SHAHED QUYYUMI MD

Endocrinology, Diabetes Metabolism

11,000

$1.9M

846
546 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

3%
patients receiving schedule three controlled substances

Avg: 1%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

48%
prescriptions for brand name drugs

Avg: 49%

$172
Average prescription price

Avg: $131

DMITRI KIRPICHNIKOV M.D.

Endocrinology, Diabetes Metabolism

10,622

$1.31M

706
604 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

54%
prescriptions for brand name drugs

Avg: 49%

$123
Average prescription price

Avg: $131

RAMANUJAPURAM RAMANUJAN MD

Endocrinology, Diabetes Metabolism

10,361

$1.14M

622
526 are 65+

2%
patients receiving schedule two controlled substances

Avg: 0%

5%
patients receiving schedule three controlled substances

Avg: 1%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

37%
prescriptions for brand name drugs

Avg: 49%

$110
Average prescription price

Avg: $131

ERNEST TERRANOVA M.D.

Endocrinology, Diabetes Metabolism

10,267

$579K

227
225 are 65+

17%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

26%
prescriptions for brand name drugs

Avg: 49%

$56
Average prescription price

Avg: $131

TOORAJ ZAHEDI MD

Endocrinology, Diabetes Metabolism

9,810

$1.19M

606
482 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

50%
prescriptions for brand name drugs

Avg: 49%

$121
Average prescription price

Avg: $131

NELLY LOO MD

Endocrinology, Diabetes Metabolism

9,611

$1.05M

213
188 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

52%
prescriptions for brand name drugs

Avg: 49%

$109
Average prescription price

Avg: $131

SAKA KAZEEM M.D.

Endocrinology, Diabetes Metabolism

8,922

$866K

545
406 are 65+

2%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

43%
prescriptions for brand name drugs

Avg: 49%

$97
Average prescription price

Avg: $131

JOSEPH ARMENIA MD

Endocrinology, Diabetes Metabolism

8,598

$946K

245
213 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

8%
patients receiving schedule three controlled substances

Avg: 1%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

39%
prescriptions for brand name drugs

Avg: 49%

$110
Average prescription price

Avg: $131

AGNIESKA GLIWA MD

Endocrinology, Diabetes Metabolism

8,558

$861K

460
325 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

5%
patients receiving schedule three controlled substances

Avg: 1%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

46%
prescriptions for brand name drugs

Avg: 49%

$101
Average prescription price

Avg: $131

MIROSLAWA KUDEJ M.D

Endocrinology, Diabetes Metabolism

8,046

$746K

429
339 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

3%
patients receiving schedule three controlled substances

Avg: 1%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

40%
prescriptions for brand name drugs

Avg: 49%

$93
Average prescription price

Avg: $131

ERASMO STURLA MD

Endocrinology, Diabetes Metabolism

7,738

$730K

293
261 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

45%
prescriptions for brand name drugs

Avg: 49%

$94
Average prescription price

Avg: $131

NAIM ABRAR M.D.

Endocrinology, Diabetes Metabolism

7,717

$940K

608
453 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

2%
patients receiving schedule three controlled substances

Avg: 1%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

41%
prescriptions for brand name drugs

Avg: 49%

$122
Average prescription price

Avg: $131

KENNETH WEISER M.D.

Endocrinology, Diabetes Metabolism

7,661

$937K

565
473 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

2%
patients receiving schedule three controlled substances

Avg: 1%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

41%
prescriptions for brand name drugs

Avg: 49%

$122
Average prescription price

Avg: $131

MATVEY BROKHIN MD

Endocrinology, Diabetes Metabolism

7,361

$936K

459
387 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

65%
prescriptions for brand name drugs

Avg: 49%

$127
Average prescription price

Avg: $131

HOWARD HUEY D.O.

Endocrinology, Diabetes Metabolism

7,247

$1.01M

491
432 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

5%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

56%
prescriptions for brand name drugs

Avg: 49%

$139
Average prescription price

Avg: $131

YELENA SHILIMOVA M.D.

Endocrinology, Diabetes Metabolism

7,091

$546K

350
256 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

55%
prescriptions for brand name drugs

Avg: 49%

$77
Average prescription price

Avg: $131

CHRISTOPHER MEJIA M.D.

Endocrinology, Diabetes Metabolism

6,886

$653K

415
296 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

44%
prescriptions for brand name drugs

Avg: 49%

$95
Average prescription price

Avg: $131

RAJINDER JAIN M.D.

Endocrinology, Diabetes Metabolism

6,851

$1.01M

378
250 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

50%
prescriptions for brand name drugs

Avg: 49%

$147
Average prescription price

Avg: $131

GLENNELL SMITH M.D., PH.D.

Endocrinology, Diabetes Metabolism

6,478

$376K

298
121 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

25%
patients receiving schedule three controlled substances

Avg: 1%

9%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

25%
prescriptions for brand name drugs

Avg: 49%

$58
Average prescription price

Avg: $131

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank